BACKGROUND: White matter disease (WMD) is frequently seen in Alzheimer's disease (AD) at neuropathological examination. It is defined as a subtotal tissue loss with a reduction of myelin, axons and oligodendrocytes as well as astrocytosis. Studies quantitatively defining the myelin loss in AD are scarce. The aim was to develop a method that could provide numerical values of myelin density in AD. The purpose was to compare the myelin contents in increasing grades of pathology of WMD, with age and cortical AD pathology as well as in different regions of the brain in AD. MATERIAL AND METHODS: Sixteen cases with AD and concomitant WMD were investigated with an in-house developed image analysis technique to determine the myelin attenuation with optical density (OD) in frontoparietal, parietal, temporal and occipital white matter on whole brain coronal sections stained for myelin with Luxol Fast Blue (LFB). The OD values in LFB were compared grouped according to Haematoxylin/Eosin (HE) evaluated mild, moderate and severe WMD or normal tissue. The OD values were also correlated with age and cortical AD pathology and compared between the different studied white matter regions. RESULTS: Increasing severity of WMD was associated with a statistically significant OD reduction. No correlation was seen between age and OD or overall cortical AD pathology. The OD values were significantly lower in frontoparietal-compared to occipital white matter. CONCLUSIONS: Myelin loss in AD with WMD is a marked morphologic component of the disease and it is possible to determine the reduction objectively in neuropathological specimens with quantitative measures. This may be of use for clinical diagnostics including brain imaging. Copyright (c) 2005 John Wiley & Sons, Ltd.
BACKGROUND:White matter disease (WMD) is frequently seen in Alzheimer's disease (AD) at neuropathological examination. It is defined as a subtotal tissue loss with a reduction of myelin, axons and oligodendrocytes as well as astrocytosis. Studies quantitatively defining the myelin loss in AD are scarce. The aim was to develop a method that could provide numerical values of myelin density in AD. The purpose was to compare the myelin contents in increasing grades of pathology of WMD, with age and cortical AD pathology as well as in different regions of the brain in AD. MATERIAL AND METHODS: Sixteen cases with AD and concomitant WMD were investigated with an in-house developed image analysis technique to determine the myelin attenuation with optical density (OD) in frontoparietal, parietal, temporal and occipital white matter on whole brain coronal sections stained for myelin with Luxol Fast Blue (LFB). The OD values in LFB were compared grouped according to Haematoxylin/Eosin (HE) evaluated mild, moderate and severe WMD or normal tissue. The OD values were also correlated with age and cortical AD pathology and compared between the different studied white matter regions. RESULTS: Increasing severity of WMD was associated with a statistically significant OD reduction. No correlation was seen between age and OD or overall cortical AD pathology. The OD values were significantly lower in frontoparietal-compared to occipital white matter. CONCLUSIONS: Myelin loss in AD with WMD is a marked morphologic component of the disease and it is possible to determine the reduction objectively in neuropathological specimens with quantitative measures. This may be of use for clinical diagnostics including brain imaging. Copyright (c) 2005 John Wiley & Sons, Ltd.
Authors: Xiaoyan Sun; David Salat; Kristen Upchurch; Rebecca Deason; Neil Kowall; Andrew Budson Journal: J Investig Med Date: 2014-10 Impact factor: 2.895
Authors: Raffaella Migliaccio; Federica Agosta; Katherine L Possin; Gil D Rabinovici; Bruce L Miller; Maria Luisa Gorno-Tempini Journal: Alzheimers Dement Date: 2012-10 Impact factor: 21.566
Authors: Ming Tong; Raiane Leão; Gina V Vimbela; Emine B Yalcin; Jared Kay; Alexander Krotow; Suzanne M de la Monte Journal: Mol Cell Neurosci Date: 2017-04-21 Impact factor: 4.314
Authors: Kenichi Oishi; Andreia Faria; Hangyi Jiang; Xin Li; Kazi Akhter; Jiangyang Zhang; John T Hsu; Michael I Miller; Peter C M van Zijl; Marilyn Albert; Constantine G Lyketsos; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa-Neto; Alan Evans; John Mazziotta; Susumu Mori Journal: Neuroimage Date: 2009-06 Impact factor: 6.556
Authors: Masafumi Ihara; Tuomo M Polvikoski; Ros Hall; Janet Y Slade; Robert H Perry; Arthur E Oakley; Elisabet Englund; John T O'Brien; Paul G Ince; Raj N Kalaria Journal: Acta Neuropathol Date: 2010-01-21 Impact factor: 17.088